Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Drug: Salmeterol and Fluticasone

Study type: Observational

Funder types: Industry

Identifiers

NCT01332409

113095

Details and patient eligibility

About

To investigate possible problems or questions in safety and effectiveness of salmeterol and fluticasone in patients with chronic obstructive pulmonary disease (bronchitis chronic / emphysema). In this special drug use investigation, onset of pneumonia shall be handled as the priority investigation item.

Enrollment: 2,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must use salmeterol and fluticasone for the first time

Exclusion criteria

• Patients with hypersensitivity to salmeterol and fluticasone
• Patients with infection which salmeterol and fluticasone is not effective
• Patients with deep mycosis

Trial design

2,000 participants in 1 patient group

Patients prescribed salmeterol and fluticasone

Description:

Patients with chronic obstructive pulmonary disease prescribed salmeterol and fluticasone during study period

Treatment:

Drug: Salmeterol and Fluticasone